We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+10.68%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.73B
AUM Growth
-$32.7M
Cap. Flow
-$304M
Cap. Flow %
-5.3%
Top 10 Hldgs %
52.96%
Holding
258
New
61
Increased
37
Reduced
51
Closed
64

Top Buys

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$103M
2
AMZN icon
Amazon
AMZN
+$91.5M
3
BIIB icon
Biogen
BIIB
+$49.7M
4
PARA
Paramount Global Class B
PARA
+$49.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$48.3M

Top Sells

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$101M
2
ROST icon
Ross Stores
ROST
+$100M
3
FIVE icon
Five Below
FIVE
+$76.2M
4
LULU icon
lululemon athletica
LULU
+$76.1M
5
INCY icon
Incyte
INCY
+$73M

Sector Composition

Rank Sector Weight
1 Healthcare 45.98%
2 Consumer Staples 5.76%
3 Technology 4.46%
4 Consumer Discretionary 4.37%
5 Communication Services 3.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VYGR icon
51
Voyager Therapeutics
VYGR
$181M
$20.7M 0.36%
3,396,000
– –
ROST icon
52
Ross Stores
ROST
$81.1B
$20.3M 0.35%
175,000
-983,117
-85% -$100M
AVTX icon
53
Avalo Therapeutics
AVTX
$955M
$20M 0.35%
16,519
– –
YUM icon
54
Yum! Brands
YUM
$40.6B
$19.9M 0.35%
+155,000
New +$18.8M
ATVI
55
DELISTED
Activision Blizzard
ATVI
$19.6M 0.34%
+256,000
New +$19M
SPB icon
56
Spectrum Brands
SPB
$2.04B
$19.5M 0.34%
+320,000
New +$16.1M
AUTL
57
Autolus Therapeutics
AUTL
$519M
$19.4M 0.34%
+10,224,000
New +$25.9M
IMCR icon
58
Immunocore
IMCR
$1.65B
$19.2M 0.33%
336,000
+20,000
+6% +$1.13M
OFIX icon
59
Orthofix Medical
OFIX
$496M
$16.4M 0.29%
+800,000
New +$14.1M
UBER icon
60
Uber
UBER
$147B
$15.4M 0.27%
624,000
-212,000
-25% -$5.8M
TMO icon
61
Thermo Fisher Scientific
TMO
$209B
$15.4M 0.27%
28,000
-22,000
-44% -$11.7M
SCPH
62
DELISTED
scPharmaceuticals
SCPH
$15.4M 0.27%
2,148,000
-344,000
-14% -$2.1M
ORLY icon
63
O'Reilly Automotive
ORLY
$73.3B
$15.2M 0.27%
270,000
-1,233,915
-82% -$66.3M
DDOG icon
64
Datadog
DDOG
$103B
$14.4M 0.25%
196,000
+68,000
+53% +$5.31M
ATEC icon
65
Alphatec Holdings
ATEC
$1.59B
$13.5M 0.24%
1,096,000
-1,340,000
-55% -$13.5M
KURA icon
66
Kura Oncology
KURA
$816M
$13.3M 0.23%
+1,072,000
New +$15.6M
FTCH
67
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$13.2M 0.23%
+2,796,000
New +$19.5M
KPTI icon
68
Karyopharm Therapeutics
KPTI
$44.4M
$13.1M 0.23%
+256,904
New +$17.8M
TGNA
69
DELISTED
TEGNA Inc
TGNA
$12.1M 0.21%
+572,000
New +$11.5M
LOW icon
70
Lowe's Companies
LOW
$119B
$12M 0.21%
60,000
-273,132
-82% -$54.6M
ERAS icon
71
Erasca
ERAS
$6.19B
$11.6M 0.2%
+2,700,000
New +$18.3M
SWAV
72
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$10.7M 0.19%
52,000
+16,000
+44% +$4.05M
JNJ icon
73
Johnson & Johnson
JNJ
$613B
$10.6M 0.18%
60,000
-20,000
-25% -$3.45M
NVDA icon
74
NVIDIA
NVDA
$5.13T
$10.5M 0.18%
+720,000
New +$10.6M
PODD icon
75
Insulet
PODD
$11.8B
$10.3M 0.18%
35,000
-1,000
-3% -$276K
1 2
3
4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Armistice Capital held 258 positions worth $5.73B, down 0.57% from $5.76B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Armistice Capital withdrew a net $304M in Q4 2022, closing 64 positions and reducing 51 holdings. Its most notable exit was Five Below, an estimated $76.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 43% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, Armistice Capital opened a new position in CVS Health worth $44.4M.

  • Armistice Capital's largest Q4 2022 buy was CVS Health: 476,000 shares worth $44.4M.
  • Armistice Capital added most to Mirati Therapeutics, Inc. Common Stock in Q4 2022, an estimated $103M increase.
  • Armistice Capital's biggest Q4 2022 reduction was Madrigal Pharmaceuticals, cutting an estimated $101M.
  • Armistice Capital fully exited Five Below in Q4 2022, selling an estimated $76.2M.
  • Armistice Capital's ten largest holdings make up 53% of its $5.73B portfolio in Q4 2022.
  • Armistice Capital opened 61 new positions and closed 64 in Q4 2022.
  • Armistice Capital's portfolio value fell 0.57% quarter-over-quarter to $5.73B.

Based on Armistice Capital's 13F filing for Q4 2022, filed 14 Feb 2023.